Download PDF
Thromb Haemost 1994; 72(06): 787-792
DOI: 10.1055/s-0038-1648962
Review Article
Schattauer GmbH Stuttgart

Thrombospondin 1 as an Enzyme Inhibitor

Philip J Hogg
The Centre for Thrombosis and Vascular Research, School of Pathology, The University of New South Wales, Sydney, Australia
› Author Affiliations
Further Information

Publication History

Received 14 June 1994

Accepted after revision 19 August 1994

Publication Date:
06 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Frazier WA. Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells. J Cell Biol 1987; 105: 625-632
    CrossrefPubMedGoogle Scholar
  • 2 Mosher DF. Physiology of thrombospondin. Annu Rev Med 1990; 41: 85-97
    CrossrefPubMedGoogle Scholar
  • 3 Mosher DF, Sun X, Sottile J, Hogg PJ. Structure-function of thrombospon-dins: Regulation of fibrinolysis and cell adhesion. In: Advances in Molecular and Cell Biology Bittar EE, Kleinman HK. eds JAI Press; Greenwich, CT: 1993. Vol 6: pp 115-132
  • 4 Lahav J. The functions of thrombospondin and its involvement in physiology and pathophysiology. Biochim Biophys Acta 1993; 1182: 01-14
    CrossrefPubMedGoogle Scholar
  • 5 Baenziger NL, Brodie GN, Majerus PW. A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci USA 1971; 68: 240-243
    CrossrefPubMedGoogle Scholar
  • 6 Baenziger NL, Brodie GN, Majerus PW. Isolation and properties of a thrombin-sensitive protein of human platelets. J Biol Chem 1972; 247: 2723-2731
    PubMedGoogle Scholar
  • 7 Lawler JW, Slayter HS, Coligan JE. Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J Biol Chem 1978; 253: 8609-8616
    PubMedGoogle Scholar
  • 8 Margossian SS, Lawler JW, Slayter HS. Physical characterization of platelet thrombospondin. J Biol Chem 1981; 256: 7495-7500
    PubMedGoogle Scholar
  • 9 Lawler J, Simons ER. Cooperative binding of calcium to thrombospondin. The effect of calcium on the circular dichroism and limited tryptic digestion of thrombospondin. J Biol Chem 1983; 258: 12098-12101
    PubMedGoogle Scholar
  • 10 Murphy-Ullrich JE, Mosher DF. Localisation of thrombospondin in clots formed in situ. Blood 1985; 66: 1098-1104
    PubMedGoogle Scholar
  • 11 Bale MD, Mosher DF. Effects of thrombospondin on fibrin polymerisation and structure. J Biol Chem 1986; 261: 862-868
    PubMedGoogle Scholar
  • 12 Lawler J, Hynes RO. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J Cell Biol 1986; 103: 1635-1648
    CrossrefPubMedGoogle Scholar
  • 13 Jaffe EA, Ruggiero JT, Leung LL, Doyle MJ, McKeown-Longo PJ, Mosher DF. Cultured fibroblasts synthesise and secrete thrombospondin and incorporate it into extracellular matrix. Proc Natl Acad Sci USA 1983; 80: 0998-1002
    CrossrefPubMedGoogle Scholar
  • 14 Mosher DF, Doyle MJ, Jaffe EA. Synthesis and secretion of thrombospondin by cultured human endothelial cells. J Cell Biol 1982; 93: 343-348
    CrossrefPubMedGoogle Scholar
  • 15 Majack RA, Cook SC, Bomstein P. Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J Cell Biol 1985; 101: 1059-1071
    CrossrefPubMedGoogle Scholar
  • 16 Framson P, Bomstein P. A semm response element and a binding site for NF-Y mediate the semm response of the human thrombospondin 1 gene. J Biol Chem 1993; 268: 4989-4996
    PubMedGoogle Scholar
  • 17 Majack RA, Goodman LV, Dixit VM. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J Cell Biol 1988; 106: 415-422
    CrossrefPubMedGoogle Scholar
  • 18 Sun X, Skorstengaard K, Mosher DF. Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin. J Cell Biol 1992; 118: 693-701
    CrossrefPubMedGoogle Scholar
  • 19 Li W-X, Howard RJ, Leung LLK. Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36. J Biol Chem 1993; 268: 16179-16184
    PubMedGoogle Scholar
  • 20 McKeown-Longo PJ, Hanning R, Mosher DF. Binding and degradation of platelet thrombospondin by cultured fibroblasts. J Cell Biol 1984; 98: 22-28
    CrossrefPubMedGoogle Scholar
  • 21 Yabkowitz R, Dixit VM. Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor. Cancer Res 1991; 51: 3648-3656
    PubMedGoogle Scholar
  • 22 O’Shea KS, Liu L-HJ, Kinnunen LH, Dixit VM. Role of the extracellular matrix protein thrombospondin in the early development of the mouse embryo. J Cell Biol 1990; 111: 2713-2723
    CrossrefPubMedGoogle Scholar
  • 23 Iruela-Arispe ML, Liska DJ, Sage EH, Bomstein P. Differential expression of thrombospondin 1,2 and 3 during murine development. Develop Dynam 1993; 197: 40-56
    CrossrefPubMedGoogle Scholar
  • 24 Reed MJ, Puolakkainen P, Lane TF, Dickerson D, Bomstein P, Sage EH. Differential expression of SPARC and thrombospondin 1 in wound repair: Immunolocalisation and in situ hybridisation. J Histochem Cytochem 1993; 41: 1467-1477
    CrossrefPubMedGoogle Scholar
  • 25 Clezardin P, Frappart L, Clerget M, Pechoux C, Delmas PD. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Cancer Res 1993; 53: 1421-1430
    PubMedGoogle Scholar
  • 26 Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 1993; 122: 497-511
    CrossrefPubMedGoogle Scholar
  • 27 Bomstein P. Thrombospondins: structure and regulation of expression. FASEB J 1992; 6: 3290-3299
    CrossrefPubMedGoogle Scholar
  • 28 Lawler J, Duquette M, Urry L, McHenry K, Smith TF. The evolution of the thrombospondin gene family. J Mol Evol 1993; 36: 509-516
    CrossrefPubMedGoogle Scholar
  • 29 O’Rourke KM, Laherty CD, Dixit VM. Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers. J Biol Chem 1992; 267: 24921-24924
    PubMedGoogle Scholar
  • 30 Vos HL, Devarayalu S, de Vries Y, Bomstein P. Thrombospondin 3 (Thbs3), a new member of the thrombospondin gene family. J Biol Chem 1992; 267: 12192-12196
    PubMedGoogle Scholar
  • 31 Lawler J, Duquette M, Whittaker CA, Adams JC, McHenry K, DeSimone DW. Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family. J Cell Biol 1993; 120: 1059-1067
    CrossrefPubMedGoogle Scholar
  • 32 Malech HL, Gallin JI. Neutrophils in human diseases. N Engl J Med 1987; 317: 687-694
    CrossrefPubMedGoogle Scholar
  • 33 Evangelista V, Piccardoni P, White JG, de Gaetano G, Cerletti C. Cathepsin G-dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: role of P-selectin-mediated cell-cell adhesion. Blood 1993; 81: 2947-2957
    PubMedGoogle Scholar
  • 34 Kreis C, la Fleur M, Menard C, Paquin R, Beaulieu AD. Thrombospondin and fibronectin are synthesised by neutrophils in human inflammatory joint disease and in a rabbit model of in vivo neutrophil activation. J Immunol 1989; 143: 1961-1968
    PubMedGoogle Scholar
  • 35 Koch AE, Friedman J, Burrows JC, Haines GK, Bouck NP. Localisation of the angiogenesis inhibitor thrombospondin in human synovial tissues. Pathobiol 1993; 61: 1-6
    CrossrefPubMedGoogle Scholar
  • 36 Hogg PJ, Owensby DA, Mosher DF, Misenheimer TM, Chesterman CN. Thrombospondin is a tight-binding competitive inhibitor of neutrophilelastase. J Biol Chem 1993; 268: 7139-7146
    PubMedGoogle Scholar
  • 37 Hogg PJ, Owensby DA, Chesterman CN. Thrombospondin 1 is a tight-binding competitive inhibitor of cathepsin G. Determination of the kinetic mechanism of inhibition and localisation of cathepsin G binding to the thrombospondin 1 type 3 repeats. J Biol Chem 1993; 268: 21811-21818
    PubMedGoogle Scholar
  • 38 Beatty K, Bieth J, Travis J. Kinetics of association of serine proteinases with native and oxidised arproteinase inhibitor and arantichymotrypsin. J Biol Chem 1980; 255: 3931-3934
    PubMedGoogle Scholar
  • 39 Schultz-Cherry S, Murphy-Ullrich JE. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J Cell Biol 1993; 122: 923-932
    CrossrefPubMedGoogle Scholar
  • 40 Misenheimer TM, Mosher DF. Calcium ion binding to thrombospondin. Thromb Haemost 1993; 69: 146
    PubMedGoogle Scholar
  • 41 Hogg PJ, Jiménez B, Chesterman CN. Identification of possible inhibitory reactive centres in thrombospondin 1 that may bind neutrophil elastase and cathepsin G. Biochemistry 1994; 33: 6531-6537
    CrossrefPubMedGoogle Scholar
  • 42 Laskowski Jr M, Kato I. Protein inhibitors of proteinases. Annu Rev Bio-chem 1980; 49: 593-626
    CrossrefPubMedGoogle Scholar
  • 43 Read RJ, James MNG. Introduction to the protein inhibitors. X-ray crystallography. In: Proteinase Inhibitors Barrett AJ, Salvesen G. eds Elsevier; New York: 1986. pp 301-333
  • 44 Bode W, Huber R. Natural protein proteinases inhibitors and their interaction with proteinases. Eur J Biochem 1992; 204: 433-451
    CrossrefPubMedGoogle Scholar
  • 45 Speziale MV, Detwiler TC. Free thiols of platelet thrombospondin. J Biol Chem 1990; 265: 17859-17867
    PubMedGoogle Scholar
  • 46 Kui C, Lin Y, Detwiler TC. Protein disulfide isomerase activity is released by activated platelets. Blood 1992; 79: 2226-2228
    PubMedGoogle Scholar
  • 47 Hofmann J, Losche W, Till U, Bosia A, Arese P, Pescarmona G, Thielmann K. Effect of decreased GSH level on human platelet functions. Artery 1980; 8: 431-436
    PubMedGoogle Scholar
  • 48 Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991; 78: 3114-3124
    PubMedGoogle Scholar
  • 49 Ellis V, Pyke C, Eriksen J, Solberg H, Danø K. The urokinase receptor: involvement in cell surface proteolysis and cancer invasion. Ann NY Acad Sci 1992; 667: 13-31
    CrossrefPubMedGoogle Scholar
  • 50 Harpel PC, Silverstein RL, Pannell R, Gurewich V, Nachman RL. Thrombospondin forms complexes with single-chain and two-chain forms of urokinase. J Biol Chem 1990; 265: 11289-11294
    PubMedGoogle Scholar
  • 51 Leung LLK, Nachman RL. Complex formation of platelet thrombospondin with fibrinogen. J Clin Invest 1982; 70: 542-549
    CrossrefPubMedGoogle Scholar
  • 52 Silverstein RL, Leung LLK, Harpel PC, Nachman RL. Complex formation of platelet thrombospondin with plasminogen: modulation of activation by tissue activator. J Clin Invest 1984; 74: 1625-1633
    CrossrefPubMedGoogle Scholar
  • 53 DePoli P, Bacon-Baguley T, Kendra-Franczak S, Cederholm MT, Walz DA. Thrombospondin interaction with plasminogen. Evidence for binding to a specific region of the kringle structure of plasminogen. Blood 1989; 73: 976-982
    PubMedGoogle Scholar
  • 54 Silverstein RL, Harpel PC, Nachman RL. Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin. J Biol Chem 1986; 261: 9959-9965
    PubMedGoogle Scholar
  • 55 Hogg PJ, Stenflo J, Mosher DF. Thrombospondin is a slow tight-binding inhibitor of plasmin. Biochemistry 1992; 31: 265-269
    CrossrefPubMedGoogle Scholar
  • 56 Stephens RW, Aumailley M, Timpl R, Reisberg T, Tapiovaara H, Myöhänen H, Murphy-Ullrich J, Vaheri A. Urokinase binding to laminin-nidogen. Eur J Biochem 1992; 207: 937-942
    CrossrefPubMedGoogle Scholar
  • 57 Anonick PK, Yoo JK, Webb DJ, Gonias SL. Characterization of the antiplasmin activity of human thrombospondin-1 in solution. Biochem J 1993; 289: 903-909
    CrossrefPubMedGoogle Scholar
  • 58 Hosokawa T, Muraishi A, Rothman VL, Papale M, Tuszynski GP. The effect of thrombospondin on invasion of fibrin gels by human A549 lung carcinoma. Oncology Res 1993; 5: 183-189
    PubMedGoogle Scholar
  • 59 Mosher DF, Misenheimer TM, Stenflo J, Hogg PJ. Modulation of fibrinolysis by thrombospondin. Ann NY Acad Sci 1992; 667: 64-70
    CrossrefPubMedGoogle Scholar